[HTML][HTML] Ten things to know about ten cardiovascular disease risk factors

HE Bays, PR Taub, E Epstein, ED Michos… - American journal of …, 2021 - Elsevier
Given rapid advancements in medical science, it is often challenging for the busy clinician to
remain up-to-date on the fundamental and multifaceted aspects of preventive cardiology and …

[HTML][HTML] Statin treatment-induced development of type 2 diabetes: from clinical evidence to mechanistic insights

U Galicia-Garcia, S Jebari, A Larrea-Sebal… - International Journal of …, 2020 - mdpi.com
Statins are the gold-standard treatment for the prevention of primary and secondary
cardiovascular disease, which is the leading cause of mortality worldwide. Despite the safety …

The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus

X Hu, Q Liu, X Guo, W Wang, B Yu, B Liang… - Cardiovascular …, 2022 - Springer
Background Previous research has linked elevated low-density lipoprotein cholesterol (LDL-
C) and remnant cholesterol (RC) with diabetes mellitus (DM). The present study aims to …

[HTML][HTML] Ten things to know about ten cardiovascular disease risk factors–2022

HE Bays, A Agarwala, C German, P Satish… - American Journal of …, 2022 - Elsevier
ABSTRACT The American Society for Preventive Cardiology (ASPC)" Ten things to know
about ten cardiovascular disease risk factors–2022" is a summary document regarding …

PCSK9 and atherosclerosis: Looking beyond LDL regulation

R Ragusa, G Basta, D Neglia… - European journal of …, 2021 - Wiley Online Library
Abstract Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) is involved in cholesterol
homeostasis. After binding to the complex low‐density lipoprotein (LDL)‐receptor, PCSK9 …

Triglyceride-rich lipoprotein metabolism: key regulators of their flux

A Gugliucci - Journal of Clinical Medicine, 2023 - mdpi.com
The residual risk for arteriosclerotic cardiovascular disease after optimal statin treatment
may amount to 50% and is the consequence of both immunological and lipid disturbances …

Using adipose‐derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?

A Mikłosz, BE Nikitiuk, A Chabowski - Obesity Reviews, 2022 - Wiley Online Library
Obesity is a critical risk factor for the development of metabolic diseases, and its prevalence
is increasing worldwide. Stem cell‐based therapies have become a promising tool for …

[HTML][HTML] Evaluation of oxidative stress levels in obesity and diabetes by the free oxygen radical test and free oxygen radical defence assays and correlations with …

MA Găman, ME Epîngeac, CC Diaconu… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Obesity and diabetes are associated with high levels of oxidative stress. In
Romanian patients with obesity and (or) diabetes, this association has not been sufficiently …

A randomized, double‐blind placebo‐controlled add‐on trial to assess the efficacy, safety, and anti‐atherogenic effect of Spirulina platensis in patients with …

SR Karizi, F Armanmehr, HG Azadi… - Phytotherapy …, 2023 - Wiley Online Library
The efficacy of spirulina platensis (S. platensis) as an add‐on therapy to metformin and its
effect on atherogenic keys in patients with uncontrolled Type 2 Diabetes Mellitus (T2DM) …

Dyslipidemia: a trigger for coronary heart disease in Romanian patients with diabetes

MA Găman, MA Cozma, EC Dobrică, N Bacalbașa… - Metabolites, 2020 - mdpi.com
Previous studies have reported age and gender disparities in the occurrence and
therapeutic approach of dyslipidemia and (or) coronary heart disease (CHD) in patients with …